Roumell Asset Management, LLC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 31 filers reported holding ETON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,258,426
+33.3%
449,4380.0%3.12%
+52.4%
Q3 2022$944,000
-19.9%
449,4380.0%2.04%
-10.9%
Q2 2022$1,178,000
-39.9%
449,4380.0%2.29%
-27.6%
Q1 2022$1,960,000
+1.7%
449,4380.0%3.17%
+23.2%
Q4 2021$1,928,000449,4382.57%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders